FIELD: medicine.
SUBSTANCE: invention relates to medicine and concerns a method for diagnosing early chronic renal disease in children, wherein enzyme-linked immunosorbent assay (ELISA) is applied determining the markers of endothelial dysfunction and growth factors: endothelin-1 (ET-1), asymmetric dimethylarginine (ADMA), homocysteine, platelet-derived growth factor AA (PDGF AA); and if four of the indicators are increased, the early stage of chronic renal disease is diagnosed in children.
EFFECT: invention ensures objectivity, elimination of the need to use a radio pharmaceutical, a possibility of implementation on an outpatient basis.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIAGNOSING PRECLINICAL SECONDARY NEPHROPATHIES IN CHILDREN | 2020 |
|
RU2753588C1 |
METHOD FOR PREDICTING TUBULO-INTERSTITIAL KIDNEY DISEASE IN CHILDREN ASSOCIATED WITH HEMOLYTIC-UREMIC SYNDROME | 2021 |
|
RU2782125C1 |
METHOD OF ASSESSING EFFECTIVENESS OF NEPHROPROTECTIVE THERAPY IN HYPERTENSIVE PATIENTS WITH STAGE C2 CHRONIC KIDNEY DISEASE | 2023 |
|
RU2810453C1 |
METHOD OF EARLY DIAGNOSTICS OF KIDNEY DAMAGE IN PATIENTS WITH THE INITIAL STAGE OF CHRONIC KIDNEY DISEASE | 2018 |
|
RU2677289C1 |
METHOD FOR EARLY DIAGNOSTICS OF PROGRESSING NEPHROPATHY IN PATIENTS WITH ARTERIAL HYPERTENSION OF1ST DEGREE | 2016 |
|
RU2632760C1 |
METHOD FOR NEPHROSCLEROSIS PREDICTION IN CHILDREN WITH CHRONIC PYELONEPHRITIS | 2016 |
|
RU2628866C1 |
EARLY DIAGNOSTIC TECHNIQUE FOR CHRONIC RENAL DISEASE | 2013 |
|
RU2566709C2 |
METHOD FOR EARLY DIAGNOSIS OF ENDOTHELIAL RENAL DYSFUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2020 |
|
RU2767701C1 |
METHOD FOR DIAGNOSTICS OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2017 |
|
RU2641964C1 |
METHOD FOR EARLY DIAGNOSIS OF CHRONIC TUBULOINTERSTITIAL RENAL INJURY IN PATIENTS WITH ANKYLOSING SPONDYLITIS | 2020 |
|
RU2725850C1 |
Authors
Dates
2021-08-17—Published
2020-09-25—Filed